Showing results (211-220 of 264) with videos related to

Sort By:
Pageof 27
International Journal of Antimicrobial Agents|November 12, 2018
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experienceMatteo Bassetti, Nadia Castaldo, Annamaria Cattelan, et al.
Journal of Clinical Medicine|October 23, 2021
Early Administration of Bamlanivimab in Combination with Etesevimab Increases the Benefits of COVID-19 Treatment: Real-World Experience from the Liguria RegionAntonio Vena, Giovanni Cenderello, Elisa Balletto, et al.
European Journal of Clinical Investigation|June 15, 2020
Bloodstream infections in critically ill patients with COVID-19Daniele Roberto Giacobbe, Denise Battaglini, Lorenzo Ball, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Echinocandins Compared to Fluconazole for Candidemia of a Urinary Tract Source: A Propensity Score AnalysisGuillermo Cuervo, Carolina Garcia-Vidal, Mireia Puig-Asensio, et al.
Journal of Chemotherapy (Florence, Italy)|August 20, 2024
COVID-19 throughout pandemic waves and virus variants: a real-life experience in an Italian hospitalSilvia Dettori, Giorgia Brucci, Federica Portunato, et al.
Journal of Chemotherapy (Florence, Italy)|December 14, 2023
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surgeClaudia Bartalucci, Alessandro Limongelli, Laura Ambra Nicolini, et al.
The Journal of Antimicrobial Chemotherapy|February 17, 2024
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoringMalgorzata Mikulska, Monica Melchio, Alessio Signori, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2025
Impact of Fluconazole Resistance on the Outcomes of Patients With Candida parapsilosis Bloodstream Infections: A Retrospective Multicenter StudyAntonio Vena, Giusy Tiseo, Marco Falcone, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 2024
Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort studyAntonio Vena, Michela Schenone, Silvia Corcione, et al.
Antibiotics (Basel, Switzerland)|December 23, 2022
T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive ExperienceDaniele Roberto Giacobbe, Francesca Crea, Paola Morici, et al.
Pageof 27